Nitroglycerin Tablet
Product Images NDC 43547-985

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Nitroglycerin (NDC 43547-985). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare U.s., Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.3mg/100tablets-label (Image 01)

Description: This text provides instructions for storing and using the medication "NTPEST WIS" in tablet form. It advises to keep the tablets at a controlled room temperature and to store them in their original container. The text also warns against crushing, chewing, or swallowing the tablets, as they are meant to be taken sublingually. Additional information includes details about the manufacturer and location.*

FDA Label Image

0.3mf/100tablets-carton (Image 02)

This text refers to Nitroglycerin Sublingual Tablets, USP. These tablets are likely used to treat conditions like chest pain (angina) by placing them under the tongue for quick absorption into the bloodstream. Nitroglycerin is a vasodilator, which means it helps widen blood vessels, improving blood flow and reducing strain on the heart. It is important to follow the prescribed dosage and instructions for proper usage.*

FDA Label Image

0.4mg/25tablets-label (Image 03)

This is a description of nitroglycerin tablets. Each tablet contains 0.4 mg of nitroglycerin and should be stored at controlled room temperature between 20-25 degrees Celsius (68-77 degrees Fahrenheit). It is important not to crush, chew, or swallow the tablets. Keep the tablets in the original container and out of reach of children. After each use, close the container tightly to prevent loss of potency. This medication is distributed by Scko Healthare US, located in Somesel, NJ, USA.*

FDA Label Image

0.4mg/25tablets/4bottles-carton (Image 04)

FDA Label Image

0.4 mg/100tablets-label (Image 05)

This is a medication label for sublingual Nitroglycerin Tablets, to be stored at controlled room temperature between 20°-25°C (68°-77°F). The instructions advise keeping the tablets in the original container, away from children, and warn against crushing, chewing, or swallowing the tablets. The text further references dosage and use information that should be reviewed from accompanying prescribing information. The product is distributed by Soloo Healthcare US, LLC and contains 100 sublingual tablets.*

FDA Label Image

0.4mg/100tablets-carton (Image 06)

FDA Label Image

0.6mg/100tablets-label (Image 07)

This text provides information about storing nitroglycerin tablets at controlled room temperature (20°-25°C/68°-77°F). It also includes dosage instructions and a warning to keep the tablets out of reach of children. Additionally, it advises not to crush, chew, or swallow the tablets and emphasizes closing the container tightly after each use to prevent loss of potency. The tablets are distributed by Sokeo Healthcare US, LLC based in Somerset, New Jersey.*

FDA Label Image

0.6mg/100tablets-carton (Image 08)

This text is detailing information about Nitroglycerin Sublingual Tablets, USP. Nitroglycerin is commonly used for the treatment of angina, a type of chest pain caused by reduced blood flow to the heart. Sublingual tablets are meant to be placed under the tongue for quick absorption into the bloodstream. These tablets are a common form of nitroglycerin medication and are often used to provide rapid relief during angina episodes.*

FDA Label Image

Chemical Structure (Nitroglycerin 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.